VRS
ADPT icon

Virginia Retirement Systems’s Adaptive Biotechnologies ADPT Stock Holding History

Virginia Retirement Systems’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$754K Sell
35,150
-10,700
-23% -$164K ﹤0.01% 838
2026
Q1 		$636K Sell
45,850
-6,500
-12% -$104K ﹤0.01% 706
2025
Q4 		$850K Sell
52,350
-1,750
-3% -$28.6K 0.01% 635
2025
Q3 		$809K Buy
+54,100
New +$659K 0.01% 645
2023
Q3 		$120K Buy
22,100
+1,700
+8% +$11.2K ﹤0.01% 914
2023
Q2 		$137K Hold
20,400
– – ﹤0.01% 947
2023
Q1 		$180K Buy
+20,400
New +$180K ﹤0.01% 964

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Virginia Retirement Systems's ADPT Position: Q2 2026 in Review

Virginia Retirement Systems reduced its Adaptive Biotechnologies (ADPT) stake by 23% in Q2 2026, selling an estimated $164K and leaving 35,150 shares worth $754K. The position accounts for ﹤0.01% of the portfolio, ranked #838.

Virginia Retirement Systems first reported a position in ADPT in Q1 2023 and has held it in 7 quarters since. The position peaked at $850K in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Virginia Retirement Systems held 35,150 shares of Adaptive Biotechnologies worth $754K as of Q2 2026.
  • Virginia Retirement Systems sold 10,700 Adaptive Biotechnologies shares in Q2 2026, an estimated $164K.
  • Adaptive Biotechnologies made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #838 holding.
  • Virginia Retirement Systems first reported a position in Adaptive Biotechnologies in Q1 2023 and has held it in 7 quarters since.
  • Virginia Retirement Systems's Adaptive Biotechnologies position peaked at $850K in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.